Key result
Among Chinese patients treated with amiodarone, the incidence of proarrhythmic events was 19.3%, while the incidence of Torsade de pointes or ventricular fibrillation was 0.17%.
Why the study?
What is the incidence and clinical profile of amiodarone-associated Torsade de Pointes in Chinese patients?
Systematic Review (n=2,454)
Yes
What is the incidence and clinical profile of amiodarone-associated Torsade de Pointes in Chinese patients?
While amiodarone-induced proarrhythmic events are relatively common in Chinese patients, the incidence of Torsade de Pointes or ventricular fibrillation is remarkably low (0.17%), though it carries a high mortality when it occurs, particularly in females with predisposing factors.
Answers are grounded in this paper and cite their sources.
Highlights need for proarrhythmia monitoring with amiodarone in Chinese patients; extends ethnicity-specific safety data from systematic evidence.
OBJECTS: Amiodarone-associated torsade de pointes (Tdp) has been reported increasingly in China in recent years. In this study, we made clinical analysis of amiodarone-associated Tdp in Chinese people. METHODS: Two major Chinese medical databases were searched to identify articles published during the last 26 years that presented data on amiodarone-associated proarrhythmic events. The articles were divided into two categories: case reports and observational studies. RESULTS: Fifty-two Chinese-language case reports with 98 patients and 2 patients registered in our hospital, total 100 patients about amiodarone-associated Tdp, were enrolled in the study. Amiodarone-associated Tdp occurred more frequently in females (68.0%, 68/100). The major primary disease of females was rheumatic heart disease (40.7%, 24/59), while that of males was coronary heart disease (45.8%, 11/24). In most patients, Tdp occurred repeatedly and terminated in 24-48 hours. Some Tdp worsen to ventricular fibrillation and caused 19 patients' death (mortality rate 21.8%, 19/87). Known predisposing factors to the development of Tdp, such as heart failure, hypokalemia, drugs combination, and bradyarrhythmia, existed in many cases. Tdp also occurred in six patients (4 females, 2 males) without any known predisposing factors except QTc interval prolongation. Fourteen observational studies each reported data from at least 100 patients who were treated with amiodarone for at least 1 month. Of 2,354 patients included in these studies, 455 patients exposed to amiodarone were reported to have proarrhythmic events (an overall incidence of 19.3%), while only 4 patients were reported to have Tdp or ventricular fibrillation (an incidence of 0.17%). CONCLUSIONS: In conclusion, approximately one-fifth of the patients have amiodarone-induced proarrhythmic events, while the incidence of Tdp or ventricular fibrillation is remarkably low. Amiodarone-associated Tdp occurred more frequently in Chinese females. Known predisposing factors for occurrence of Tdp prevailed in Chinese patients. QTc interval prolongation may be an independent risk factor of amiodarone-associated Tdp.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2006) conducted a systematic review in Amiodarone-associated Torsade de Pointes (n=2,454). Amiodarone was evaluated on Torsade de pointes or ventricular fibrillation. Among Chinese patients treated with amiodarone, the incidence of proarrhythmic events was 19.3%, while the incidence of Torsade de pointes or ventricular fibrillation was 0.17%.
Synapse has enriched 10 related papers. Consider them for comparative context: